Clinical Trial Update: Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates termination of a Phase 1/2 study evaluating arsenic trioxide with or without tretinoin in patients with hematologic cancers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)
• TRETINOIN (TRETINOIN)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Leukemia, Lymphoma | Phase 1, Phase 2 | Status: TERMINATED